What researchers published on Chronic lymphocytic leukaemia
935 papers, newest first.
Showing 20 of 935
Not labelled yetOptimizing CLL treatment after covalent BTK inhibition.Clinical advances in hematology & oncology : H&O
Not labelled yetTerminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.Blood
Not labelled yetADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.Cancer medicine
Not labelled yetEffects of Dioscin on NLRP3 Inflammasome Expression and Apoptosis in Chronic Lymphocytic Leukemia Cells.Immunopharmacology and immunotoxicology
Not labelled yetOutcomes of Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors (BTKi): A Retrospective Study From a Tertiary Healthcare Center in North India.Cureus
Not labelled yetReal-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study.Leukemia research
Not labelled yetReal-World Treatment Patterns, Tolerability, and Outcomes Among Patients With CLL/SLL Treated With First-Line Ibrutinib, Acalabrutinib, or Zanubrutinib in the US Community Oncology Setting: A Retrospective Cohort Study.EJHaem
Not labelled yetDecision-Making on First-Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi-Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy.Hematological oncology
Not labelled yetThe evolving evidence ecosystem in chronic lymphocytic leukemia: from linear hierarchies to integrated synthesis.Expert review of hematology
Not labelled yetA thyroid nodule consistent with chronic lymphocytic leukemia.Endocrinology, diabetes & metabolism case reports
Not labelled yetAptamers in cancer research: Focus on leukemia.Chinese medical journal
Not labelled yetBeyond age: The prognostic impact of frailty on in-hospital outcomes in chronic lymphocytic leukemia.Journal of geriatric oncology
Not labelled yetExanthematous drug eruption with reactive T-cell atypia in a patient with accelerated chronic lymphocytic leukemia.International journal of women's dermatology
Not labelled yetQuantitative systems pharmacology modeling identifies synthetic lethality opportunities with DNA damage response inhibitors in ATM-deficient chronic lymphocytic leukemia - a computational simulation study.Journal of pharmacokinetics and pharmacodynamics
ReviewChronic lymphocytic leukemia: recent advances and emerging therapeutic strategies.Blood research
Not labelled yetPersonalized Prediction of Venetoclax-Associated Tumor Lysis Syndrome in Acute Myeloid Leukemia Using Drug Exposure, Genetic Polymorphisms, and Clinical-Laboratory Characteristics.Drug design, development and therapy
Not labelled yetShortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real-World Study.Cancer medicine
Not labelled yetComment on "Costs and consequences of cardiovascular toxicity due to Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia".Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
Case reportConcurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report.Blood transfusion = Trasfusione del sangue
Case reportLeukemia Cutis at the Diagnosis of Chronic Lymphocytic Leukemia: A Case Report.Cureus